wire

VPEE Student Journalist Caroline Coyer reflects on the highlights of the Research and Industry Showcase and Industry Reception, from the development of robots with a sense of touch to the possibility of using AI to enhance public safety at global events.

At the Festival of Engineering, VPEE Student Journalist Caroline Coyer attended the 'Interstellar Engineering' event and shared her insights on the exciting overlap between space exploration, medical advancements, and engineering.

One in three dying people in England and Wales was severely or overwhelmingly affected by pain in the last week of life, with bereaved people reporting how difficult it was to get joined-up support from health and care professionals at home.

Durham University has a commitment to supporting local young people, as part of the 'In our City and Region' element of our University Strategy Refresh 2017-2027.

Researchers have proposed a new classification system for angina patients, co-authoring a scientific consensus statement introducing new terminology for ischaemic heart disease, which is the leading cause of death in men and women worldwide.

A cancer drug that unlocks the anti-inflammatory power of the immune system could help to reduce the risk of future heart attacks, according to research part-funded by the British Heart Foundation.

£1.1m award for pioneering ovarian cancer research project Researchers from the University of Glasgow have received £1.1m to support the development of new technologies which could improve the diagnosis and treatment of ovarian cancer.

Mothers under the age of 20 are at the greatest risk of being involved in care proceedings in the 10 years after having their first child, finds a new study report led by UCL researchers.

Researchers at the University of Glasgow have received funding to begin a new project seeking to improve the accessibility of bone density scanning for people living with a muscle waste condition.

Five research projects at UCL are benefiting from over £800,000 in total funding announced by Muscular Dystrophy UK, to improve diagnosis, monitor progression and test potential new treatments for muscle wasting and weakening conditions.

A study involving 900 students in six countries found that a short programme of empathy lessons led to measurable, positive changes in their conduct, emotional awareness and curiosity about different cultures.

A new study has revealed that when academics express political opinions on X (formerly Twitter), it can damage how credible the public thinks they are. New research, published in a CESifo working paper from Dr Eleonora Alabrese from the University of Bath; Francesco Capozza, Research Associate at the WZB Berlin Social Science Center and Prashant Garg, an Economics PhD candidate at Imperial College Business School reveals that expressing political views on social media can erode public trust in academics.

New results from the LUX-ZEPLIN (LZ) collaboration involving UCL researchers have put the best-ever limits on weakly interacting massive particles (WIMPs), a leading candidate for what makes up our universe's invisible mass. Figuring out the nature of dark matter, the invisible substance that makes up most of the mass in our universe, is one of the greatest puzzles in physics.

Pain may be the most prevalent and severe symptom reported by individuals with long Covid, according to a new study led by UCL researchers.

Writing in The Conversation, Professor Seirian Sumner (UCL Biosciences) explains where all the wasps have gone this summer and invites people to record insects, including wasps, that they see in flower patches as part of the UK Pollinator Monitoring Scheme.

A fifth of patients in some areas of the North of England have Long Covid, according to a study which includes university of Manchester researchers.

The WHO has declared current Mpox outbreaks are of 'International Concern', but how does the situation differ from previous public health emergencies?

The Medicines and Healthcare Products Regulatory Agency (MHRA) has licensed the immunotherapy drug, Lecanemab, for use in the early stages of Alzheimer's disease in the UK, following decades of work supported by UCL research.